We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
+21.39%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$2.5B
AUM Growth
+$482M
Cap. Flow
+$84.9M
Cap. Flow %
3.4%
Top 10 Hldgs %
30.71%
Holding
250
New
26
Increased
102
Reduced
86
Closed
11

Top Buys

Rank Stock Value
1
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$18.6M
2
XYL icon
Xylem
XYL
+$13.8M
3
HD icon
Home Depot
HD
+$13.6M
4
ISTB icon
iShares Core 1-5 Year USD Bond ETF
ISTB
+$13.1M
5
SEIC icon
SEI Investments
SEIC
+$11.6M

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
2
JPIN icon
JPMorgan Diversified Return International Equity ETF
JPIN
+$13.7M
3
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$10.6M
4
AMZN icon
Amazon
AMZN
+$10.5M
5
WFC icon
Wells Fargo
WFC
+$4.05M

Sector Composition

Rank Sector Weight
1 Technology 21.37%
2 Financials 15.24%
3 Healthcare 10.98%
4 Consumer Discretionary 7.31%
5 Communication Services 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
101
Ultragenyx Pharmaceutical
RARE
$2.46B
$2.51M 0.1%
32,108
-1,000
-3% -$66.2K
INTC icon
102
Intel
INTC
$413B
$2.18M 0.09%
36,379
+1,442
+4% +$86.2K
IJH icon
103
iShares Core S&P Mid-Cap ETF
IJH
$121B
$2.17M 0.09%
61,005
-1,450
-2% -$48.2K
IBM icon
104
IBM
IBM
$213B
$2.06M 0.08%
17,812
+3,842
+28% +$446K
EEM icon
105
iShares MSCI Emerging Markets ETF
EEM
$27.5B
$1.96M 0.08%
49,076
-419,320
-90% -$15.7M
WFC icon
106
Wells Fargo
WFC
$254B
$1.94M 0.08%
75,886
-148,115
-66% -$4.05M
OTIS icon
107
Otis Worldwide
OTIS
$27.9B
$1.89M 0.08%
+33,240
New +$1.72M
MIC
108
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$1.78M 0.07%
58,077
-1,000
-2% -$27.7K
CARR icon
109
Carrier Global
CARR
$49.8B
$1.7M 0.07%
+76,275
New +$1.42M
KMB icon
110
Kimberly-Clark
KMB
$37.6B
$1.66M 0.07%
11,741
+14
+0.1% +$1.93K
SPLV icon
111
Invesco S&P 500 Low Volatility ETF
SPLV
$7.24B
$1.49M 0.06%
30,019
-1,898
-6% -$93.3K
VWO icon
112
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$1.38M 0.06%
34,892
-8,906
-20% -$330K
NVDA icon
113
NVIDIA
NVDA
$4.6T
$1.32M 0.05%
138,880
-1,080
-0.8% -$8.74K
SPHQ icon
114
Invesco S&P 500 Quality ETF
SPHQ
$19B
$1.21M 0.05%
34,173
+392
+1% +$13.3K
AEP icon
115
American Electric Power
AEP
$70.4B
$1.18M 0.05%
14,818
-191
-1% -$15.6K
IJT icon
116
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.13B
$1.12M 0.05%
13,240
-78
-0.6% -$6.08K
AMGN icon
117
Amgen
AMGN
$209B
$1.11M 0.04%
4,699
+47
+1% +$10.7K
TMO icon
118
Thermo Fisher Scientific
TMO
$214B
$1.1M 0.04%
3,049
-3
-0.1% -$1.01K
IJK icon
119
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.6B
$1.09M 0.04%
19,468
-100
-0.5% -$5.19K
XBI icon
120
State Street SPDR S&P Biotech ETF
XBI
$10B
$1.08M 0.04%
9,650
-60
-0.6% -$5.91K
SPIB icon
121
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$968K 0.04%
26,540
-395
-1% -$14.1K
SHY icon
122
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$964K 0.04%
11,133
+540
+5% +$46.8K
EDIT icon
123
Editas Medicine
EDIT
$399M
$954K 0.04%
32,250
– –
IWO icon
124
iShares Russell 2000 Growth ETF
IWO
$14.1B
$928K 0.04%
4,484
+36
+0.8% +$6.73K
ABBV icon
125
AbbVie
ABBV
$465B
$907K 0.04%
9,243
+611
+7% +$53.8K
3 4
5
6 7

Similar funds

AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
GFM
GF Fund Management Guangzhou, China $5.98B AUM 80.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Crestwood Advisors Group's Q2 2020 Portfolio in Review

As of Q2 2020, Crestwood Advisors Group held 250 positions worth $2.5B, up 24% from $2.02B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Crestwood Advisors Group deployed $84.9M of net new capital in Q2 2020, opening 26 new positions and adding to 102 existing holdings. Its largest new stake was Xylem: 208,372 shares worth $13.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $15.7M trimmed.

  • Crestwood Advisors Group's largest Q2 2020 buy was Xylem: 208,372 shares worth $13.5M.
  • Crestwood Advisors Group added most to iShares Core MSCI EAFE ETF in Q2 2020, an estimated $18.6M increase.
  • Crestwood Advisors Group's biggest Q2 2020 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $15.7M.
  • Crestwood Advisors Group fully exited Cue Biopharma in Q2 2020, selling an estimated $3.83M.
  • Crestwood Advisors Group's ten largest holdings make up 31% of its $2.5B portfolio in Q2 2020.
  • Crestwood Advisors Group opened 26 new positions and closed 11 in Q2 2020.
  • Crestwood Advisors Group's portfolio value rose 24% quarter-over-quarter to $2.5B.

Based on Crestwood Advisors Group's 13F filing for Q2 2020, filed 14 Aug 2020.